BAFNA PHARMACEUTICALS
Back to Cashflow Statement
|
BAFNA PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹1.06 Cr | ₹-0.85 Cr | ₹10 Cr | ₹-4.81 Cr | ₹12 Cr |
What is the latest Cash Flow from Financing Activities ratio of BAFNA PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹1.06 Cr |
| Mar2024 | ₹-0.85 Cr |
| Mar2023 | ₹10 Cr |
| Mar2022 | ₹-4.81 Cr |
| Mar2021 | ₹12 Cr |
How is Cash Flow from Financing Activities of BAFNA PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.06 Cr | Positive | |
| Mar2024 | ₹-0.85 Cr | Negative | |
| Mar2023 | ₹10 Cr | Positive | |
| Mar2022 | ₹-4.81 Cr | Negative | |
| Mar2021 | ₹12 Cr | - | |
Compare Cash Flow from Financing Activities of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹502.1 Cr | -7.7% | 18.5% | 192.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,593.0 Cr | 2% | 6.7% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,737.0 Cr | 3.5% | 2.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,290.0 Cr | 4.6% | 9.9% | 41.5% | Stock Analytics | |
| CIPLA | ₹117,327.0 Cr | -0.3% | 3.7% | -2.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,994.0 Cr | 1.1% | 5.9% | 6.6% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | -7.7% |
18.5% |
192.1% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses